http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107365359-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K9-008
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K9-00
filingDate 2017-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107365359-B
titleOfInvention Synthesis method of vancomycin chiral functional monomer
abstract The invention relates to a synthesis method of a vancomycin chiral functional monomer, and belongs to the technical field of organic synthesis and synthesis of functional high polymer intermediates. Completely dissolving vancomycin in an organic phase, and then adding an acyl chloride compound, wherein the molar ratio of the vancomycin to the acyl chloride compound is as follows: 1.0: 1.0-2.5, reacting for 0.5-4.0 h at the temperature of 0-80 ℃ to obtain vancomycin chiral functional monomer VanR, wherein Van represents vancomycin, and R represents a group substituted on vancomycin and is an alkylene group. The vancomycin derivative synthesized by the method contains terminal alkenyl in the structure, and can be used as a valuable functional monomer in the preparation of high molecular polymers.
priorityDate 2017-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004058732-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006130418-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID543805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416002589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415722795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID38042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455787888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13528

Total number of triples: 28.